Carlo Fabris

3.8k total citations
160 papers, 3.0k citations indexed

About

Carlo Fabris is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Carlo Fabris has authored 160 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Epidemiology, 76 papers in Hepatology and 44 papers in Oncology. Recurrent topics in Carlo Fabris's work include Liver Disease Diagnosis and Treatment (67 papers), Hepatitis C virus research (55 papers) and Hepatitis B Virus Studies (33 papers). Carlo Fabris is often cited by papers focused on Liver Disease Diagnosis and Treatment (67 papers), Hepatitis C virus research (55 papers) and Hepatitis B Virus Studies (33 papers). Carlo Fabris collaborates with scholars based in Italy, United States and France. Carlo Fabris's co-authors include Mario Pirisi, Pierluigi Toniutto, Edmondo Falleti, Davide Bitetto, Annarosa Cussigh, Rosalba Minisini, Ezio Fornasiere, Sara Cmet, Claudio Avellini and Elisabetta Fontanini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gastroenterology.

In The Last Decade

Carlo Fabris

156 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlo Fabris Italy 29 1.7k 1.5k 478 430 382 160 3.0k
John Koskinas Greece 32 2.0k 1.2× 2.1k 1.4× 467 1.0× 314 0.7× 387 1.0× 140 3.5k
Hitoshi Takagi Japan 32 1.3k 0.8× 1.5k 1.0× 963 2.0× 657 1.5× 246 0.6× 212 3.5k
Pierluigi Toniutto Italy 35 2.6k 1.5× 2.7k 1.7× 938 2.0× 400 0.9× 512 1.3× 179 4.2k
Michio Imawari Japan 34 1.4k 0.9× 1.6k 1.1× 544 1.1× 632 1.5× 527 1.4× 175 3.7k
Jane Collier United Kingdom 32 2.4k 1.4× 2.2k 1.4× 930 1.9× 531 1.2× 288 0.8× 91 4.3k
B Portmann United Kingdom 35 1.6k 1.0× 1.9k 1.3× 1.2k 2.5× 400 0.9× 179 0.5× 83 3.6k
Luisa Garcı́a-Buey Spain 24 1.3k 0.8× 1.4k 0.9× 188 0.4× 258 0.6× 198 0.5× 70 2.3k
Daniela Cabibi Italy 35 2.6k 1.6× 1.5k 1.0× 677 1.4× 330 0.8× 731 1.9× 160 4.2k
Gian Ludovico Rapaccini Italy 28 1.3k 0.8× 1.4k 0.9× 593 1.2× 385 0.9× 158 0.4× 112 2.7k
E. Del Ninno Italy 27 3.6k 2.1× 3.8k 2.4× 337 0.7× 283 0.7× 200 0.5× 74 4.6k

Countries citing papers authored by Carlo Fabris

Since Specialization
Citations

This map shows the geographic impact of Carlo Fabris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Fabris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Fabris more than expected).

Fields of papers citing papers by Carlo Fabris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Fabris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Fabris. The network helps show where Carlo Fabris may publish in the future.

Co-authorship network of co-authors of Carlo Fabris

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Fabris. A scholar is included among the top collaborators of Carlo Fabris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Fabris. Carlo Fabris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toniutto, Pierluigi, Edmondo Falleti, Sara Cmet, et al.. (2022). Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients. Journal of Hepatology. 77(1). 152–162. 17 indexed citations
2.
Toniutto, Pierluigi, Davide Bitetto, Edmondo Falleti, et al.. (2014). Biliary strictures after liver transplantation: Role of interleukin 28B genotypes in cyclosporine treated. International Journal of Surgery. 12(10). 1082–1087. 1 indexed citations
3.
Fabris, Carlo, C. Vandelli, Pierluigi Toniutto, et al.. (2010). Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases. Journal of Gastroenterology and Hepatology. 26(2). 328–333. 16 indexed citations
4.
Minisini, Rosalba, Carlo Fabris, Pierluigi Toniutto, & Mario Pirisi. (2009). Combinatorial use of single nucleotide polymorphisms to help predict liver fibrosis in patients with hepatitis C infections. Expert Opinion on Medical Diagnostics. 3(4). 355–370. 1 indexed citations
5.
Falleti, Edmondo, Carlo Fabris, Pierluigi Toniutto, et al.. (2009). Interleukin-6 Polymorphisms and Gender: Relationship with the Occurrence of Hepatocellular Carcinoma in Patients with End-Stage Liver Disease. Oncology. 77(5). 304–313. 34 indexed citations
6.
Bitetto, Davide, Carlo Fabris, Edmondo Falleti, et al.. (2009). Vitamin D and the risk of acute allograft rejection following human liver transplantation. Liver International. 30(3). 417–44. 73 indexed citations
7.
Toniutto, Pierluigi, Carlo Fabris, Davide Bitetto, et al.. (2008). R-1626, a specific oral NS5B polymerase inhibitor of hepatitis C virus.. PubMed. 11(10). 738–49. 11 indexed citations
8.
Fabris, Carlo, Carlo Smirne, Pierluigi Toniutto, et al.. (2008). Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C. Clinical Chemistry and Laboratory Medicine (CCLM). 46(2). 253–9. 10 indexed citations
9.
Fabris, Carlo, Pierluigi Toniutto, Edmondo Falleti, et al.. (2008). MTHFR C677T Polymorphism and Risk of HCC in Patients With Liver Cirrhosis: Role of Male Gender and Alcohol Consumption. Alcoholism Clinical and Experimental Research. 33(1). 102–107. 38 indexed citations
10.
Toniutto, Pierluigi, Carlo Fabris, Elisa Fumolo, et al.. (2008). Prevalence and risk factors for delayed adrenal insufficiency after liver transplantation. Liver Transplantation. 14(7). 1014–1019. 6 indexed citations
11.
Falleti, Edmondo, Carlo Fabris, Pierluigi Toniutto, et al.. (2007). Genetic Polymorphisms of Inflammatory Cytokines and Liver Fibrosis Progression Due To Recurrent Hepatitis C. Journal of Interferon & Cytokine Research. 27(3). 239–246. 15 indexed citations
12.
Fabris, Carlo, Pierluigi Toniutto, Davide Bitetto, et al.. (2005). Low fibrosis progression of recurrent hepatitis C in apolipoprotein E ɛ4 carriers: relationship with the blood lipid profile. Liver International. 25(6). 1128–1135. 17 indexed citations
13.
Toniutto, Pierluigi, Carlo Fabris, Nadia Bortolotti, et al.. (2004). Evaluation of donor hepatic iron concentration as a factor of early fibrotic progression after liver transplantation. Journal of Hepatology. 41(2). 307–311. 8 indexed citations
14.
Toniutto, Pierluigi, Carlo Fabris, Laura Mariuzzi, et al.. (2004). Carriage of the Apolipoprotein E-e 4 Allele and Histologic Outcome of Recurrent Hepatitis C After Antiviral Treatment. American Journal of Clinical Pathology. 122(3). 428–433. 20 indexed citations
15.
Pirisi, Mario, Pierluigi Toniutto, Alessandro Uzzau, et al.. (2000). Carriage ofHFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients. Cancer. 89(2). 297–302. 27 indexed citations
16.
Pirisi, Mario, Pierluigi Toniutto, Carlo Fabris, et al.. (1998). Factors Associated with Serum HCV RNA Positivity in Anti-HCV Antibody Positive Intravenous Drug Users. Journal of Clinical Epidemiology. 51(5). 423–427. 8 indexed citations
17.
Pirisi, Mario, et al.. (1996). Prognostic value of serum alpha-1-antitrypsin in hepatocellular carcinoma. European Journal of Cancer. 32(2). 221–225. 9 indexed citations
18.
Fabris, Carlo, Mario Pirisi, Giorgio Soardo, et al.. (1994). Value of serum C-reactive protein measurement in the detection of hepatocellular carcinoma superimposed on liver cirrhosis. Journal of Cancer Research and Clinical Oncology. 120(4). 229–232. 10 indexed citations
19.
Meggiato, T., Daniela Basso, Carlo Fabris, et al.. (1991). CAR-3 and CA 19-9 serum levels in pancreatic cancer: any differences between two epitopes of the same mucin-like glycoprotein?. PubMed. 8(4). 171–7. 1 indexed citations
20.
Leandro, Gioacchino, Daniela Basso, Carlo Fabris, et al.. (1989). α-Fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis. Journal of Cancer Research and Clinical Oncology. 115(3). 276–278. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Koskinas Breakdown of academic impact, for papers by Hitoshi Takagi Breakdown of academic impact, for papers by Pierluigi Toniutto Breakdown of academic impact, for papers by Michio Imawari Breakdown of academic impact, for papers by Jane Collier Breakdown of academic impact, for papers by B Portmann Breakdown of academic impact, for papers by Luisa Garcı́a-Buey Breakdown of academic impact, for papers by Daniela Cabibi Breakdown of academic impact, for papers by Gian Ludovico Rapaccini Breakdown of academic impact, for papers by E. Del Ninno
Rankless by CCL
2026